Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$16.92 - $28.96 $326,539 - $558,899
-19,299 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$20.0 - $31.88 $28,180 - $44,918
-1,409 Reduced 6.8%
19,299 $386,000
Q2 2019

Aug 14, 2019

BUY
$30.67 - $37.86 $16,377 - $20,217
534 Added 2.65%
20,708 $668,000
Q1 2019

May 13, 2019

BUY
$22.22 - $32.21 $448,266 - $649,804
20,174 New
20,174 $650,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.